Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H Begent

Showing results (71-80 of 166) with videos related to

Pageof 17
Sort By:
Cancer|June 1, 1986
Successful management of metastatic and primary germ cell tumors in the brainG J Rustin, E S Newlands, K D Bagshawe, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 1, 1991
Optimum management of pineal germ cell tumoursD B Smith, E S Newlands, R H Begent, et al.
British Journal of Cancer|February 1, 1989
The effect of intensity of administered treatment on the outcome of germ cell tumours treated with POMB/ACE chemotherapyS M Crawford, E S Newlands, R H Begent, et al.
British Journal of Urology|July 1, 1987
The current management of testicular cancerG J Rustin, E S Newlands, K D Bagshawe, et al.
Cancer|November 1, 1983
Central nervous system metastases of choriocarcinoma. 23 years' experience at Charing Cross HospitalA Athanassiou, R H Begent, E S Newlands, et al.
International Journal of Cancer|March 12, 1991
A phase-I study of repeated therapy with radiolabelled antibody to carcinoembryonic antigen using intermittent or continuous administration of cyclosporin A to suppress the immune responseJ A Ledermann, R H Begent, C Massof, et al.
Journal of the Royal Society of Medicine|March 31, 2000
Anaphylactic reaction to radioimmunotherapy despite plasmapheresis to remove anti-mouse antibodiesM J Verhaar-Langereis, K F Eagle, P A Keep, et al.
British Journal of Cancer|January 1, 1995
Galactosylated streptavidin for improved clearance of biotinylated intact and F(ab')2 fragments of an anti-tumour antibodyD Marshall, R B Pedley, R G Melton, et al.
British Journal of Cancer|March 1, 1996
Polyethylene glycol modification of a galactosylated streptavidin clearing agent: effects on immunogenicity and clearance of a biotinylated anti-tumour antibodyD Marshall, R B Pedley, J A Boden, et al.
British Journal of Obstetrics and Gynaecology|January 1, 1986
Developments in chemotherapy for medium- and high-risk patients with gestational trophoblastic tumours (1979-1984)E S Newlands, K D Bagshawe, R H Begent, et al.
Pageof 17

Showing results (71-80 of 166) with videos related to

Sort By:
Pageof 17
Cancer|June 1, 1986
Successful management of metastatic and primary germ cell tumors in the brainG J Rustin, E S Newlands, K D Bagshawe, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 1, 1991
Optimum management of pineal germ cell tumoursD B Smith, E S Newlands, R H Begent, et al.
British Journal of Cancer|February 1, 1989
The effect of intensity of administered treatment on the outcome of germ cell tumours treated with POMB/ACE chemotherapyS M Crawford, E S Newlands, R H Begent, et al.
British Journal of Urology|July 1, 1987
The current management of testicular cancerG J Rustin, E S Newlands, K D Bagshawe, et al.
Cancer|November 1, 1983
Central nervous system metastases of choriocarcinoma. 23 years' experience at Charing Cross HospitalA Athanassiou, R H Begent, E S Newlands, et al.
International Journal of Cancer|March 12, 1991
A phase-I study of repeated therapy with radiolabelled antibody to carcinoembryonic antigen using intermittent or continuous administration of cyclosporin A to suppress the immune responseJ A Ledermann, R H Begent, C Massof, et al.
Journal of the Royal Society of Medicine|March 31, 2000
Anaphylactic reaction to radioimmunotherapy despite plasmapheresis to remove anti-mouse antibodiesM J Verhaar-Langereis, K F Eagle, P A Keep, et al.
British Journal of Cancer|January 1, 1995
Galactosylated streptavidin for improved clearance of biotinylated intact and F(ab')2 fragments of an anti-tumour antibodyD Marshall, R B Pedley, R G Melton, et al.
British Journal of Cancer|March 1, 1996
Polyethylene glycol modification of a galactosylated streptavidin clearing agent: effects on immunogenicity and clearance of a biotinylated anti-tumour antibodyD Marshall, R B Pedley, J A Boden, et al.
British Journal of Obstetrics and Gynaecology|January 1, 1986
Developments in chemotherapy for medium- and high-risk patients with gestational trophoblastic tumours (1979-1984)E S Newlands, K D Bagshawe, R H Begent, et al.
Pageof 17